查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829753

2025年全球神经栓塞设备市场报告

Neurovascular Embolization Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，神经血管栓塞器械的市场规模稳定成长，预计2024年将达到13.2亿美元，2025年将达到13.8亿美元，复合年增长率为4.8%。预测期内的增长归因于神经血管疾病盛行率的上升、老年人口的增长、对微创手术的需求、医疗基础设施的改善以及医疗支出的增加。

预计未来几年神经血管栓塞器械市场规模将强劲成长，到2029年将达到17.8亿美元，复合年增长率为6.5%。预测期内的成长归因于新兴市场应用的不断扩展、对以患者为中心的护理的日益重视、对神经血管疾病认识的不断提高、成像技术的进步以及研发投入的不断增加。预测期内的主要趋势包括个人化治疗方法、人工智慧在治疗计划中的整合、下一代栓塞材料的出现、向门诊和门诊治疗的转变以及创新栓塞技术的开发。

神经血管栓塞装置是一种医疗工具，透过阻断或改变血流来处理脑部和中枢神经系统内的不规则血管。它们在神经介入手术中发挥重要作用，旨在治疗动脉瘤、介入神经放射学(AVM) 和动静脉瘻管 (AVF) 等可能导致出血或其他不良后果的疾病。

神经血管栓塞器械类别的主要产品包括栓塞弹簧圈、液体栓塞系统、血流路径改道支架、动脉瘤夹及其他相关产品。栓塞弹簧圈是由铂和不銹钢等材料製成的柔性装置，用于阻断血管内的血流。它们可用于治疗多种疾病，包括中风和出血性中风，以及脑动脉瘤和动静脉畸形。这些器械的终端使用者包括医院和门诊手术中心等。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供神经栓塞器材市场统计数据，包括全球市场规模、区域份额、神经栓塞器材市场份额的竞争对手、详细的神经栓塞器材细分市场、市场趋势以及行业商机。这些神经栓塞器材市场研究报告透过深入分析产业现状和未来趋势，为您提供全面的展望。

我们对该市场未来五年6.5%的成长率预测与先前保持不变。下降的主要原因是美国与其他国家之间关税的影响。这种影响将透过对法国铂金微弹簧圈征收关税对美国产生直接影响，从而提高动脉瘤修復系统的价格，并影响挽救生命的介入神经放射学手术的可负担性。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响也将更加广泛。

出血发生率的上升预计将推动神经血管栓塞装置市场的发展。出血是指透过皮肤或黏膜破裂在内部或外部发生的异常且无法控制的出血。人口老化、高血压加剧以及抗凝血剂的广泛使用导致了出血的流行。神经血管栓塞装置透过阻断异常血管，从而控制出血并避免进一步的脑损伤，在治疗出血性中风方面发挥关键作用。例如，伦敦国王学院最近进行的一项研究预测，到 2050 年，英国70 至 95 岁人群中因脑出血（一种特定类型的出血）导致的病例和死亡人数将增加 59.4%。因此，脑出血盛行率的上升正在推动神经血管栓塞装置市场的成长。

为了应对脑动脉瘤并增强市场竞争力，神经血管栓塞器械领域的主要企业正专注于开发技术先进的产品，例如屏蔽技术。屏蔽技术是指旨在提高脑动脉瘤治疗器械的有效性和安全性，同时提高其整体耐用性和使用寿命的先进功能。例如，总部位于爱尔兰的医疗技术公司Medtronic PLC) 于2022年6月在印度推出了其第四代流量转向器——采用屏蔽技术的Pipeline Vantage。此器械的设计特点经过改进，使其在血管内手术中更易于使用且可靠。该器械旨在促进血管内膜细胞增殖，从而辅助微创治疗动脉瘤，降低破裂风险并改善患者预后。

2023年5月，美国医疗科技公司史赛克（Stryker Corporation）以5.3亿美元收购了Cerus Endovascular Ltd。史赛克的这项策略性措施旨在增强其在提供治疗颅内动脉瘤的创新医疗设备方面的专业知识，包括Contour神经血管系统和NeqStent线圈辅助血流转向器等产品。 Cerus Endovascular Ltd总部位于爱尔兰，专注于开发用于治疗颅内动脉瘤的尖端神经血管栓塞器械。

神经血管栓塞设备市场的主要参与企业包括强生公司、雅培实验室、美敦力公司、贺利氏控股、史赛克公司、波士顿科学公司、钟化公司、泰尔茂公司、B Braun Melsungen AG、Cook Medical LLC、Integer Holdings Corporation、Merit Medical Systems Inc、Penumbra Inc、Asahi Inteccop Cop、Mr.alr Ltd. Co KG、Rapid Medical Ltd、Emboline Inc、InspireMD Inc、QXMedical LLC、Vesalio LLC 和 EmbolX Inc。

2024年神经栓塞设备市场最大的地区是北美。预计亚太地区将成为预测期内成长最快的地区。神经栓塞设备市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

神经血管栓塞装置市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、美国、英国、加拿大、义大利和西班牙。

神经血管栓塞器械市场包括颗粒栓塞、可分离球囊、血管栓塞和栓塞微球的销售。该市场的价值为“出厂价”，即商品製造商或创造者销售的商​​品价值，无论是出售给其他营业单位（包括下游製造商、批发商、经销商和零售商），还是直接出售给最终客户。该市场商品的价值还包括商品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球神经血管栓塞设备：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球神经栓塞设备市场：成长率分析
  • 全球神经栓塞设备市场表现：规模与成长，2019-2024
  • 全球神经栓塞设备市场预测：规模与成长，2024-2029，2034
  • 全球神经栓塞设备：总目标市场（TAM）

第六章 市场细分

  • 全球神经栓塞设备市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 栓塞线圈
  • 液体栓塞系统
  • 血流晶粒支架
  • 动脉瘤夹
  • 其他的
  • 全球神经栓塞设备市场（按治疗、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 缺血性中风解决方案
  • 出血性中风解决方案
  • 全球神经栓塞设备市场（按适应症、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 脑动脉瘤
  • 动静脉畸形
  • 其他的
  • 全球神经栓塞设备市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 其他的
  • 全球神经血管栓塞设备市场：栓塞线圈细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 可拆卸线圈
  • 白金裸线圈
  • 水凝胶涂层弹簧圈
  • 全球神经血管栓塞设备市场：液体栓塞系统细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 戊二醛液体栓塞
  • Onyx液体栓塞系统
  • 全球神经血管栓塞设备市场：血流晶粒支架细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 层级构造支架
  • 用于动脉瘤治疗的分流器
  • 全球神经血管栓塞设备市场：动脉瘤夹细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 钛夹
  • 不銹钢夹
  • 全球神经栓塞设备市场：其他细分市场、按类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 栓塞球囊
  • 微导管

第七章 区域和国家分析

  • 全球神经栓塞设备市场：2019-2024 年、2024-2029 年和 2034 年区域表现和预测
  • 全球神经栓塞设备市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 神经栓塞装置市场：竞争格局
  • 神经栓塞设备市场：公司简介
    • Johnson & Johnson
    • Abbott Laboratories
    • Medtronic plc
    • Heraeus Holding
    • Stryker Corporation

第31章：其他领先和创新企业

  • Boston Scientific Corporation
  • Kaneka Corporation
  • Terumo Corporation
  • B Braun Melsungen AG
  • Cook Medical LLC
  • Integer Holdings Corporation
  • Merit Medical Systems Inc
  • Penumbra Inc
  • Asahi Intecc Co Ltd
  • MicroVention Inc
  • Balt USA LLC
  • Imperative Care Inc
  • InNeuroCo Inc
  • Acandis GmbH & Co KG
  • Rapid Medical Ltd

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年神经栓塞设备市场：提供新机会的国家
  • 2029年神经栓塞设备市场：细分市场带来新机会
  • 2029年神经栓塞设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r30785u

Neurovascular embolization devices are medical tools utilized to address irregular blood vessels in the brain or central nervous system by obstructing or altering blood flow. They play a crucial role in neuro-interventional treatments aimed at addressing conditions such as aneurysms, arteriovenous malformations (AVMs), and arteriovenous fistulas (AVFs) that could lead to bleeding or other adverse outcomes.

The primary products within the category of neurovascular embolization devices comprise embolization coils, liquid embolic systems, flow diversion stents, aneurysm clips, and other related items. Embolization coils, constructed from materials such as platinum or stainless steel, are flexible devices employed to block blood flow within vessels. They are utilized in diverse treatments such as ischemic and hemorrhagic stroke solutions and are indicated for conditions such as brain aneurysms and arteriovenous malformations. These devices are utilized by various end-users including hospitals, ambulatory surgical centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The neurovascular embolization devices market research report is one of a series of new reports from The Business Research Company that provides neurovascular embolization devices market statistics, including the neurovascular embolization devices industry global market size, regional shares, competitors with neurovascular embolization devices market share, detailed neurovascular embolization devices market segments, market trends, and opportunities, and any further data you may need to thrive in the neurovascular embolization devices industry. These neurovascular embolization devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neurovascular embolization devices market size has grown steadily in recent years. It will grow from $1.32 billion in 2024 to $1.38 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to the increased prevalence of neurovascular disorders, the rising geriatric population, the demand for minimally invasive procedures, improved healthcare infrastructure, and increased healthcare expenditure.

The neurovascular embolization devices market size is expected to see strong growth in the next few years. It will grow to $1.78 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to expanding applications in emerging markets, emphasis on patient-centric care, rising awareness about neurovascular disorders, advancements in imaging technologies, and increasing investments in research and development. Major trends in the forecast period include personalized treatment approaches, integration of artificial intelligence in treatment planning, the emergence of next-generation embolic materials, shift towards outpatient and ambulatory procedures and development of innovative embolization techniques.

The forecast of 6.5% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on platinum microcoils from France, raising prices for aneurysm treatment systems and impacting the affordability of life-saving neurointerventional procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of hemorrhages is anticipated to drive the neurovascular embolization devices market forward. Hemorrhages represent abnormal and uncontrollable bleeding occurring either internally within the body or externally through breaks in the skin or mucous membranes. Factors contributing to the prevalence of hemorrhages include aging populations, heightened occurrences of hypertension, and expanded usage of anticoagulant medications. Neurovascular embolization devices play a crucial role in managing hemorrhagic strokes by blocking abnormal blood vessels, thereby reducing bleeding and averting further brain damage. For example, recent research conducted by King's College London indicates an expected 59.4% increase in cases and deaths from intracerebral hemorrhage (a specific type of hemorrhage) among individuals aged 70 to 95 across the UK by 2050. Consequently, the mounting prevalence of hemorrhages propels the growth of the neurovascular embolization devices market.

Major companies in the neurovascular embolization devices sector are concentrating on the development of technologically advanced products, such as shield technology, to address brain aneurysms and enhance their competitive position in the market. Shield Technology denotes an advanced attribute aimed at augmenting the effectiveness and safety of these devices while also contributing to their overall durability and longevity. For example, in June 2022, Medtronic PLC, an Ireland-based healthcare technology company, introduced the Pipeline Vantage with Shield Technology, a fourth-generation flow diverter in India. This device incorporates enhanced design features to enhance usability and reliability during endovascular procedures. By fostering cell growth in the blood vessel's inner lining, the device provides a scaffold that aids in the minimally invasive treatment of aneurysms, reduces the risk of rupture, and enhances patient outcomes.

In May 2023, Stryker Corporation, a US-based medical technology company, completed the acquisition of Cerus Endovascular Ltd for $530 million. This strategic move by Stryker was aimed at strengthening its expertise in offering innovative medical devices tailored for treating intracranial aneurysms, including products such as the contour neurovascular system and the neqstent coil-assisted flow diverter. Cerus Endovascular Ltd, headquartered in Ireland, specializes in the development of cutting-edge neurovascular embolization devices designed specifically for the treatment of intracranial aneurysms.

Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, InNeuroCo Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Emboline Inc, InspireMD Inc, QXMedical LLC, Vesalio LLC, EmbolX Inc

North America was the largest region in the neurovascular embolization devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neurovascular embolization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neurovascular embolization devices market consists of sales of particle embolic, detachable balloons, vascular plugs, and embolization microspheres. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurovascular Embolization Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurovascular embolization devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurovascular embolization devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurovascular embolization devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Embolization Coils; Liquid Embolic Systems; Flow Diversion Stents; Aneurysm Clips; Other Products
  • 2) By Treatment: Ischemic Stroke Solution; Hemorrhagic Stroke Solutions
  • 3) By Indication: Brain Aneurysms; Arteriovenous Malformation; Other Indications
  • 4) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users
  • Subsegments:
  • 1) By Embolization Coils: Detachable Coils; Bare Platinum Coils; Coils With Hydrogel Coatings
  • 2) By Liquid Embolic Systems: Gluteraldehyde-Based Liquid Embolization; Onyx Liquid Embolic System
  • 3) By Flow Diversion Stents: Stents With Dual-Layer Technology; Flow Diverters For Aneurysm Treatment
  • 4) By Aneurysm Clips: Titanium Clips; Stainless Steel Clips
  • 5) By Other Products: Balloons For Embolization; Microcatheters
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Heraeus Holding; Stryker Corporation; Boston Scientific Corporation; Kaneka Corporation; Terumo Corporation; B Braun Melsungen AG; Cook Medical LLC; Integer Holdings Corporation; Merit Medical Systems Inc; Penumbra Inc; Asahi Intecc Co Ltd; MicroVention Inc; Balt USA LLC; Imperative Care Inc; InNeuroCo Inc; Acandis GmbH & Co KG; Rapid Medical Ltd; Emboline Inc; InspireMD Inc; QXMedical LLC; Vesalio LLC; EmbolX Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neurovascular Embolization Devices Market Characteristics

3. Neurovascular Embolization Devices Market Trends And Strategies

4. Neurovascular Embolization Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Neurovascular Embolization Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Neurovascular Embolization Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Neurovascular Embolization Devices Market Growth Rate Analysis
  • 5.4. Global Neurovascular Embolization Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Neurovascular Embolization Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Neurovascular Embolization Devices Total Addressable Market (TAM)

6. Neurovascular Embolization Devices Market Segmentation

  • 6.1. Global Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Embolization Coils
  • Liquid Embolic Systems
  • Flow Diversion Stents
  • Aneurysm Clips
  • Other Products
  • 6.2. Global Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ischemic Stroke Solution
  • Hemorrhagic Stroke Solutions
  • 6.3. Global Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Brain Aneurysms
  • Arteriovenous Malformation
  • Other Indications
  • 6.4. Global Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users
  • 6.5. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Embolization Coils, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Detachable Coils
  • Bare Platinum Coils
  • Coils With Hydrogel Coatings
  • 6.6. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Liquid Embolic Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gluteraldehyde-Based Liquid Embolization
  • Onyx Liquid Embolic System
  • 6.7. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Flow Diversion Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stents With Dual-Layer Technology
  • Flow Diverters For Aneurysm Treatment
  • 6.8. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Aneurysm Clips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Titanium Clips
  • Stainless Steel Clips
  • 6.9. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloons For Embolization
  • Microcatheters

7. Neurovascular Embolization Devices Market Regional And Country Analysis

  • 7.1. Global Neurovascular Embolization Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Neurovascular Embolization Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neurovascular Embolization Devices Market

  • 8.1. Asia-Pacific Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neurovascular Embolization Devices Market

  • 9.1. China Neurovascular Embolization Devices Market Overview
  • 9.2. China Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neurovascular Embolization Devices Market

  • 10.1. India Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neurovascular Embolization Devices Market

  • 11.1. Japan Neurovascular Embolization Devices Market Overview
  • 11.2. Japan Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neurovascular Embolization Devices Market

  • 12.1. Australia Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neurovascular Embolization Devices Market

  • 13.1. Indonesia Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neurovascular Embolization Devices Market

  • 14.1. South Korea Neurovascular Embolization Devices Market Overview
  • 14.2. South Korea Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neurovascular Embolization Devices Market

  • 15.1. Western Europe Neurovascular Embolization Devices Market Overview
  • 15.2. Western Europe Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neurovascular Embolization Devices Market

  • 16.1. UK Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neurovascular Embolization Devices Market

  • 17.1. Germany Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neurovascular Embolization Devices Market

  • 18.1. France Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neurovascular Embolization Devices Market

  • 19.1. Italy Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neurovascular Embolization Devices Market

  • 20.1. Spain Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neurovascular Embolization Devices Market

  • 21.1. Eastern Europe Neurovascular Embolization Devices Market Overview
  • 21.2. Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neurovascular Embolization Devices Market

  • 22.1. Russia Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neurovascular Embolization Devices Market

  • 23.1. North America Neurovascular Embolization Devices Market Overview
  • 23.2. North America Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neurovascular Embolization Devices Market

  • 24.1. USA Neurovascular Embolization Devices Market Overview
  • 24.2. USA Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neurovascular Embolization Devices Market

  • 25.1. Canada Neurovascular Embolization Devices Market Overview
  • 25.2. Canada Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neurovascular Embolization Devices Market

  • 26.1. South America Neurovascular Embolization Devices Market Overview
  • 26.2. South America Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neurovascular Embolization Devices Market

  • 27.1. Brazil Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neurovascular Embolization Devices Market

  • 28.1. Middle East Neurovascular Embolization Devices Market Overview
  • 28.2. Middle East Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neurovascular Embolization Devices Market

  • 29.1. Africa Neurovascular Embolization Devices Market Overview
  • 29.2. Africa Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neurovascular Embolization Devices Market Competitive Landscape And Company Profiles

  • 30.1. Neurovascular Embolization Devices Market Competitive Landscape
  • 30.2. Neurovascular Embolization Devices Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Heraeus Holding Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Neurovascular Embolization Devices Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Kaneka Corporation
  • 31.3. Terumo Corporation
  • 31.4. B Braun Melsungen AG
  • 31.5. Cook Medical LLC
  • 31.6. Integer Holdings Corporation
  • 31.7. Merit Medical Systems Inc
  • 31.8. Penumbra Inc
  • 31.9. Asahi Intecc Co Ltd
  • 31.10. MicroVention Inc
  • 31.11. Balt USA LLC
  • 31.12. Imperative Care Inc
  • 31.13. InNeuroCo Inc
  • 31.14. Acandis GmbH & Co KG
  • 31.15. Rapid Medical Ltd

32. Global Neurovascular Embolization Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurovascular Embolization Devices Market

34. Recent Developments In The Neurovascular Embolization Devices Market

35. Neurovascular Embolization Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Neurovascular Embolization Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Neurovascular Embolization Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Neurovascular Embolization Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer